PI3Kinases in Diabetes Mellitus and Its Related Complications
Recent studies have shown that phosphoinositide 3-kinases (PI3Ks) have become the target of many pharmacological treatments, both in clinical trials and in clinical practice. PI3Ks play an important role in glucose regulation, and this suggests their possible involvement in the onset of diabetes mel...
Main Authors: | Angelo Maffei, Giuseppe Lembo, Daniela Carnevale |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/19/12/4098 |
Similar Items
-
Contribution of Natural Inhibitors to the Understanding of the PI3K/PDK1/PKB Pathway in the Insulin-mediated Intracellular Signaling Cascade
by: Jae Youl Cho, et al.
Published: (2008-11-01) -
Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance
by: Marcia N. Paddock, et al.
Published: (2019-04-01) -
PI3K inhibitors in thrombosis and cardiovascular disease
by: Tom N. Durrant, et al.
Published: (2020-01-01) -
In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against <i>Leishmania donovani</i> and <i>Trypanosoma brucei</i>
by: Trong-Nhat Phan, et al.
Published: (2020-04-01) -
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer
by: Aikaterini Emmanouilidi, et al.
Published: (2019-05-01)